a mí me pasan todas , pero todas literal !!! hasta cuándo lcsm jajaj

41 years…
My dad died 41 years ago today, just 3 mths after being dx w/ #lungcancer . He was 41 years old.

My dad’s been gone as long as he was alive.

Reflecting on the impact of his life, death & advancements in research. We’ve made a huge dent, BUT still have far to go.
#LCSM

A Japanese study evaluated the purported concern of omitting LN dissections during lung cancer surgery for GGO-dominant lung cancers. It calls into question why surgery is offered for this population in the first place. #lcsm #CSP2005 sciencedirect.com/science/articl…

How can we improve the patient experience around #radiotherapy ?

Dr Thitikorn Nuamek (Thitikorn Nuamek (Pao)), Clinical Research Fellow The Christie Charity, shared research @BTOG using online patient questionnaires which highlighted gaps to do just this. Have a listen to his recap.

#LCSM

Ph III IMscin001 trial of Subcutaneous (sc) vs IV Atezolizumab in adv NSCLC JTO & JTO CRR:

- mOS 10.7 v 10.1m
- median admin time sc: 7mins
- similar toxicity

A step forward in implementing anti-PD(L)1 across growing nos. of indications?

OncoAlert #LCSM
jto.org/article/S1556-…

Interesting multi-omic analysis of previously classified SCLC cell lines (YAP1+), identifies that these tumors represent diseases that ‘mimic’ SCLC- in this case- SMARCA4-deficient thoracic tumors, that have a poor prognosis

Clinical Cancer Research OncoAlert #LCSM

aacrjournals.org/clincancerres/…

Proud of our The Shields Lab member, Katie Minton, with a successful poster presentation today IU Simon Comprehensive Cancer Center #CancerResearchDay on an exciting novel therapy that is pre-clinically effective in MYC amplified #SCLC .

#ResearchCuresCancer #LCSM #nothingsmallaboutit SmallCellSMASHERS

Los wachos dolidos son peor que una wacha jaja lcsm 🤮

We teamed up w Break Through Cancer in a $2M partnership to find strategies that leave no ALK+ cancer cells alive.

ALK+ cancer often recurs; BTC will work to identify & test novel therapies to ultimately leave no ALK cells alive.

Read more 👇 alkpositive.org/blog/2024/5/5/…
#Research #LCSM

Exciting day in the The Shields Lab today with a new grad student, #SCLC tissue culture, preparation of RNA, cDNA, qRT-PCRs, and a successful, collaborative multiD lab meeting!

#LCSM #nothingsmallaboutit #researchcurescancer The White Ribbon Project™ IU Simon Comprehensive Cancer Center

Thank you Peter Ujhazy Peter Ujhazy, National Cancer Institute and all of the Small Cell Lung Cancer Consortium members for a great #SCLC #LCSM meeting. Amazing to see the progress over 10 years since we first met to make a plan to accelerate progress for patients with SCLC.

North Carolina is considering rescinding the health exemption for public use of masks. This means an #immunocompromised person with #cancer , #transplant , etc could be arrested or fined if they #WearAMask . 🤦🏻‍♀️Pls speak up! #lcsm #bcsm #leusm #lymsm #mmsm #MedTwitter #OncTwitter 👇

Groundbreaking study by Sutherland Lab and colleagues challenging the dogma of “YAP1” neuroendocrine subtype in #SCLC .

This research finally clarifies how YAP1+ actually appears in SMARCA4-deficient undifferentiated thoracic tumors, not in #SCLC .

#LCSM #researchcurescancer

Thanks to Yan Leyfman, MD 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 for this commentary of our publication! we need to move liquid biopsies to frontline therapy International Society of Liquid Biopsy #lungcancer #lcsm
Innovations in Thoracic Oncology and the Promise of Liquid Biopsies with Dr. Luis Raez ncbi.nlm.nih.gov/pmc/articles/P…

So what's in store for lung cancer at #asco24 @asco
Apart from Laura and Adriatic which are plenary sessions
We have some interesting data coming up #LCSM
1 - will Sacituzumab Govitecan be better than Docetaxel in second line NSCLC? EVOKE -01 study .

2 - will addition of…

#ESTRO24 NARLAL2 ph 3 trial, n=350

With modern RT/QA, dose escalation (mean GTVp 95 Gy, GTVn 74 Gy) improved loco-regional control with no increase in toxicity observed in stage III NSCLC

#radonc #lcsm

On 14 May we'll join the Institute for Social Policy Development, @lungcancereu, @walceonlus2006 and many more to discuss the status of lung cancer in Europe and tangible actions to improve screening implementation. #LCSM

Register to join us online 👇 lungcancerpolicynetwork.com/lung-cancer-po…

Join us next week for the livestream of our Central and Eastern Europe roundtable to hear leading clinicians, researchers and policymakers discuss how lung cancer screening can be implemented effectively in the region . #LCSM
Register now 👇 lungcancerpolicynetwork.com/lung-cancer-po…

Who’s ready for the next #EGFR Summit ?!

#EGFR #NSCLC #LCSM @egfrresisters